Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS) [Corrigendum]

This article refers to:

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)

Chen CH, Lim SJ, Oh JK, et al. Clin Interv Aging. 2020;15;111–121.

During the publication process, two of the authors names were presented incorrectly on page 111. The author list should be presented as:

Chung-Hwan Chen¹

Seung-Jae Lim²

Jong-Keon Oh³

Tsan-Wen Huang⁴

Yu-Hong Zeng⁵

Meng-Ting Wu⁶

Hui-Lin Yang⁷

Jason Pui-Yin Cheung⁸

Ji Wan Kim⁹

Jeong Hee Han¹⁰

Li Huo¹¹

Tsung-Jung Lin¹²

Gang Zhou¹¹

Wen-Shuo Wu¹²

¹Department of Orthopedics and Orthopedic Research Center, Kaohsiung Municipal Ta-Tung Hospital and Kaohsiung Medical University Hospital, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan; ²Department of Orthopedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; ³Department of Orthopedics, Korea University Guro Hospital, Seoul, South Korea; ⁴Department of Orthopaedic Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan; ⁵Department of Osteoporosis, Honghui Hospital, Xi’an Jiaotong University, Xian, People’s Republic of China; ⁶Division of Neurosurgery, Department of Surgery, Cheng Hsin General Hospital, Taipei, Taiwan; ⁷Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; ⁸Department of Orthopaedics and Traumatology, The University of Hong Kong, Hong Kong, People’s Republic of China; ⁹Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, South Korea; ¹⁰Department of Medical Quality and Regulatory Affairs, Lilly Korea Ltd., Seoul, South Korea; ¹¹Lilly China Drug Development and Medical Affairs Center, Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, People’s Republic of China; ¹²Department of Medical Affairs, Eli Lilly and Company (Taiwan), Inc., Taipei, Taiwan